UAE Blood Glucose Monitoring Devices Market By Product Type (Self Blood Glucose Monitoring Devices {Glucometers, Test Strips, Lancets} v/s Continuous Glucose Monitoring Devices {Sensors, Transmitters & Receivers, Integrated Insulin Pumps}), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital, Others), By Region, Competition Forecast & Opportunities, 2027
UAE blood glucose monitoring devices market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing instances of diabetic patients in the country. The rapidly growing population and increasing diabetic cases among the younger population of the country are also driving the growth of the UAE blood glucose monitoring devices market in the upcoming five years.
Blood glucose monitoring devices are self-defining medical devices that are used to monitor the irregular concentration of glucose in the blood. Diabetic patients require blood glucose monitoring devices to keep a regular check on their sugar intake and change blood sugar levels. Patients suffering from type 1 diabetes produce less amount of insulin. Or the insulin being produced by the pancreas in the human body gets attacked by the immune system thus the digestion of sugar molecules fails. Blood glucose monitoring devices monitor the level of sugar in the blood. The devices can be self-monitoring device that includes a glucometer to analyze the blood sample, test strips to procure the sample on and to be inserted in the glucometer for the test, and lancets to prick the finger to collect a blood sample. The device usually comes with an in-built screen or mobile-based applications that display the sugar level. There are continuous blood glucose monitoring devices too, that is usually worn on the body. In certain cases, the sensors are placed under the skin of the belly or on the back of the arm. A transmitter is attached to the sensor and sends information to the wireless monitor usually clipped over the belt.
Growing Patients’ Demand, Drive Market Growth
Rapidly increasing cases of diabetes in the country is alarming. As of 2021, 990 people in every 1000 count of all age population suffered from diabetes according to International Diabetes Federation. The increasing geriatric population further guarantees the increasing count of diabetic patients. 1 in every 5 people in the country over the age of 65 suffers from diabetes. By 2019, over 19% of the adult population aged between 20 years to 79 years were suffering from type II diabetes. The country stands at the 10th largest population suffering from diabetes on the world scale.
Diabetes is not a nominal disease that simply lowers the insulin level and disrupts sugar digestion. Patients suffering from diabetes are at high risk of heart failure, heart attacks, and other cardiovascular diseases. The immune system of the patient suffers too, the patient is often at higher risk of contracting an infectious disease, and severity in various cases might lead to death. Only diabetes may account for 8.8% of mortalities in 2021, in the country; but the mortality rate due to cardiovascular diseases is as high as 40%. Moreover, during the recent pandemic condition, diabetic patients were at the highest risk. The experts do call diabetes a “silent pandemic” in UAE for its haphazardly increasing numbers.
Market Segmentation
The UAE blood glucose monitoring devices market is segmented by product type, application, end-user, competitional landscape, and regional distribution. Based on product type, the market is bifurcated into self-blood glucose monitoring devices and continuous glucose monitoring devices. Self-blood glucose monitoring devices include glucometers, test strips, and lancets. Continuous glucose monitoring devices include sensors, transmitters & receivers, and integrated insulin pumps. By application, the market is further segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. Based on end users, the market is fragmented into home care settings, hospitals, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi, Dubai, Sharjah, and the rest of UAE.
Company Profile
Abbott Laboratories SA, Roche Diagnostics Middle East FZCO, Johnson & Johnson Middle East FZ-LLC, Medtronic Meta FZ-LLC, Becton, Dickinson, and Company UAE, Nipro Middle East FZE, B. Braun Medical Gulf FZ-LLC, among others is a partial list of major market players of the companies responsible for the growth of UAE blood glucose monitoring devices market.
Report Scope:
In this report, UAE blood glucose monitoring devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in UAE blood glucose monitoring devices market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Blood glucose monitoring devices are self-defining medical devices that are used to monitor the irregular concentration of glucose in the blood. Diabetic patients require blood glucose monitoring devices to keep a regular check on their sugar intake and change blood sugar levels. Patients suffering from type 1 diabetes produce less amount of insulin. Or the insulin being produced by the pancreas in the human body gets attacked by the immune system thus the digestion of sugar molecules fails. Blood glucose monitoring devices monitor the level of sugar in the blood. The devices can be self-monitoring device that includes a glucometer to analyze the blood sample, test strips to procure the sample on and to be inserted in the glucometer for the test, and lancets to prick the finger to collect a blood sample. The device usually comes with an in-built screen or mobile-based applications that display the sugar level. There are continuous blood glucose monitoring devices too, that is usually worn on the body. In certain cases, the sensors are placed under the skin of the belly or on the back of the arm. A transmitter is attached to the sensor and sends information to the wireless monitor usually clipped over the belt.
Growing Patients’ Demand, Drive Market Growth
Rapidly increasing cases of diabetes in the country is alarming. As of 2021, 990 people in every 1000 count of all age population suffered from diabetes according to International Diabetes Federation. The increasing geriatric population further guarantees the increasing count of diabetic patients. 1 in every 5 people in the country over the age of 65 suffers from diabetes. By 2019, over 19% of the adult population aged between 20 years to 79 years were suffering from type II diabetes. The country stands at the 10th largest population suffering from diabetes on the world scale.
Diabetes is not a nominal disease that simply lowers the insulin level and disrupts sugar digestion. Patients suffering from diabetes are at high risk of heart failure, heart attacks, and other cardiovascular diseases. The immune system of the patient suffers too, the patient is often at higher risk of contracting an infectious disease, and severity in various cases might lead to death. Only diabetes may account for 8.8% of mortalities in 2021, in the country; but the mortality rate due to cardiovascular diseases is as high as 40%. Moreover, during the recent pandemic condition, diabetic patients were at the highest risk. The experts do call diabetes a “silent pandemic” in UAE for its haphazardly increasing numbers.
Market Segmentation
The UAE blood glucose monitoring devices market is segmented by product type, application, end-user, competitional landscape, and regional distribution. Based on product type, the market is bifurcated into self-blood glucose monitoring devices and continuous glucose monitoring devices. Self-blood glucose monitoring devices include glucometers, test strips, and lancets. Continuous glucose monitoring devices include sensors, transmitters & receivers, and integrated insulin pumps. By application, the market is further segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. Based on end users, the market is fragmented into home care settings, hospitals, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi, Dubai, Sharjah, and the rest of UAE.
Company Profile
Abbott Laboratories SA, Roche Diagnostics Middle East FZCO, Johnson & Johnson Middle East FZ-LLC, Medtronic Meta FZ-LLC, Becton, Dickinson, and Company UAE, Nipro Middle East FZE, B. Braun Medical Gulf FZ-LLC, among others is a partial list of major market players of the companies responsible for the growth of UAE blood glucose monitoring devices market.
Report Scope:
In this report, UAE blood glucose monitoring devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- UAE Blood Glucose Monitoring Devices Market, By Product Type:
- Self-Blood Glucose Monitoring Devices
- Glucometers
- Test Strips
- Lancets
- Continuous Glucose Monitoring Devices
- Sensors
- Transmitters & Receivers
- Integrated Insulin Pumps
- UAE Blood Glucose Monitoring Devices Market, By Application:
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- UAE Blood glucose monitoring devices Market, By End User:
- Home Care Settings
- Hospital
- Others
- UAE Blood Glucose Monitoring Devices Market, By Region:
- Abu Dhabi
- Dubai
- Sharjah
- Rest of UAE
Company Profiles: Detailed analysis of the major companies present in UAE blood glucose monitoring devices market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE BLOOD GLUCOSE MONITORING DEVICES MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. UAE BLOOD GLUCOSE MONITORING DEVICES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Self Blood Glucose Monitoring Devices v/s Continuous Glucose Monitoring Devices)
6.2.2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
6.2.3. By End User (Home Care Settings, Hospital, Others)
6.2.4. By Region
6.2.5. By Company (2021)
6.3. Product Market Map
7. UAE SELF BLOOD GLUCOSE MONITORING DEVICES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Glucometers, Test Strips, Lancets)
7.2.2. By Application
7.2.3. By End User
8. UAE CONTINUOUS BLOOD GLUCOSE MONITORING DEVICES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Sensors, Transmitters & Receivers, Integrated Insulin Pumps)
8.2.2. By Application
8.2.3. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
11. POLICY & REGULATORY LANDSCAPE
12. PRICING ANALYSIS
13. IMPORT-EXPORT ANALYSIS
14. UAE ECONOMIC PROFILE
15. COMPETITIVE LANDSCAPE
15.1. Competition Outlook
15.2. Company Profiles
15.2.1. Abbott Laboratories SA
15.2.2. Roche Diagnostics Middle East FZCO
15.2.3. Johnson & Johnson Middle East FZ-LLC
15.2.4. Medtronic Meta FZ-LLC
15.2.5. Becton, Dickinson, and Company UAE
15.2.6. Nipro Middle East FZE
15.2.7. B. Braun Medical Gulf FZ-LLC
16. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE BLOOD GLUCOSE MONITORING DEVICES MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. UAE BLOOD GLUCOSE MONITORING DEVICES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Self Blood Glucose Monitoring Devices v/s Continuous Glucose Monitoring Devices)
6.2.2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
6.2.3. By End User (Home Care Settings, Hospital, Others)
6.2.4. By Region
6.2.5. By Company (2021)
6.3. Product Market Map
7. UAE SELF BLOOD GLUCOSE MONITORING DEVICES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Glucometers, Test Strips, Lancets)
7.2.2. By Application
7.2.3. By End User
8. UAE CONTINUOUS BLOOD GLUCOSE MONITORING DEVICES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Sensors, Transmitters & Receivers, Integrated Insulin Pumps)
8.2.2. By Application
8.2.3. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
11. POLICY & REGULATORY LANDSCAPE
12. PRICING ANALYSIS
13. IMPORT-EXPORT ANALYSIS
14. UAE ECONOMIC PROFILE
15. COMPETITIVE LANDSCAPE
15.1. Competition Outlook
15.2. Company Profiles
15.2.1. Abbott Laboratories SA
15.2.2. Roche Diagnostics Middle East FZCO
15.2.3. Johnson & Johnson Middle East FZ-LLC
15.2.4. Medtronic Meta FZ-LLC
15.2.5. Becton, Dickinson, and Company UAE
15.2.6. Nipro Middle East FZE
15.2.7. B. Braun Medical Gulf FZ-LLC
16. STRATEGIC RECOMMENDATIONS
